ClinicalTrials.gg
RecruitingNCT06744036Updated May 22, 2026

Effects of Including Interferential Current in a Therapeutic Exercise Program in Individuals With Knee Osteoarthritis

An interventional study of Therapeutic Exercise and Interferential Current in Osteoarthritis, Knee, sponsored by University of Nove de Julho. Recruiting at 1 site in Brazil. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by University of Nove de Julho · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 79 studies in Osteoarthritis, Knee with a site in Brazil — 12 open to participants now, 12 under way, 2 of them phase 3. Osteoarthritis, Knee · Brazil.

Planned enrollment
14th of 77
138 · median 66
Started
2025
with 3 others
No phase
50 of 79
9 open now
Primary completion
2026-06
later than 4 of 11 live
Registered
73rd of 79
by date
Lead sponsor
8 of 79
University of Nove de Julho

Among the 79 studies in Osteoarthritis, Knee with a site in Brazil, this one is the 14th largest by planned enrollment of the 77 interventional ones that give a count, is one of 4 that started in 2025, is one of 50 with no phase, reaches primary completion later than 4 of the 11 other live ones, and was the 73rd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 79 studies in Osteoarthritis, Knee with a site in Brazil are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 40 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Osteoarthritis, Knee with a site in Brazil, or all of them as a file.
02

Study summary

The first-line treatment for knee osteoarthritis (KOA) in terms of pain and functionality is physical exercise. The use of interferential current (IC) associated with other resources may be beneficial in reducing pain intensity and improving functionality. However, the effects of its simultaneous use with therapeutic exercise have not yet been fully established. The aim of this project will be to evaluate the effects of including IC in a therapeutic exercise program in relation to pain intensity, functionality, self-efficacy, maximum voluntary contraction and overall perceived effect in individuals with KOA. Therefore, research participants of both sexes, between 40 and 75 years old, with a clinical diagnosis of unilateral KOA, who have knee pain for more than 3 months, with a minimum score of 3 points on the numerical pain scale, morning stiffness for less than 30 minutes, crepitation, bone sensitivity, and absence of palpable heat will be recruited. The research participants will be randomized into three groups: therapeutic exercises (n=46) and therapeutic exercises + IC (n=46) and therapeutic exercises + IC placebo (n=46). Eight consecutive weeks of treatment will be carried out. The research participants will be evaluated before the intervention, after the end of the intervention of eight consecutive weeks of intervention and after four weeks at the end of the last week of intervention, through the instruments: numeric pain scale (NPS), Knee Injury and Osteoarthritis Outcome Score (KOOS), patient-specific functional scale (EFEP), Pain self-efficacy questionnaire (PSEQ), maximum voluntary isometric contraction (MVIC), 30-second sit-to-stand test (TSL30s), global perception scale (EPG). For data analysis, a normality test will be used to verify the distribution of the data and a statistical test appropriate for the appropriate intra and inter-group comparisons, thus considering two factors in the comparisons, time and group. A significance level of 5% will be adopted.

Read the detailed description

The sample size calculation was revised to reflect a more appropriate and accurate outcome: The sample size was calculated based on the study's primary outcome, the Pain subscale of the KOOS. For the calculation, a clinically important difference between groups of 11.8 points was considered, a value derived from a systematic review specific to individuals with knee osteoarthritis undergoing non-surgical interventions, rounded to approximately 12 points for clinical interpretation purposes. A standard deviation of 18.2 points was adopted, based on a study involving individuals with mild to moderate knee osteoarthritis under non-surgical management. Considering a statistical power of 80% and α = 0.05, the required sample size of 38 per group was estimated. After adding 20% to account for possible losses, the final sample size was set at 46 participants per group.

Silva MDC, Perriman DM, Fearon AM, Couldrick JM, Scarvell JM. Minimal important change and difference for knee osteoarthritis outcome measurement tools after non-surgical interventions: a systematic review. BMJOpen. 2023;13(5):e063026. Published 2023 May 18. doi:10.1136/bmjopen-2022-063026

03

Conditions studied

  • Osteoarthritis, Knee
04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • both sexes
  • between 40 years old and 75 years old
  • with a clinical diagnosis of unilateral KOA
  • Who has had knee pain for more than 3 months
  • With a minimum score of 3 points on the numerical pain scale
  • Morning stiffness for less than 30 minutes
  • Crepitus
  • Bone tenderness and absence of palpable heat

Exclusion criteria

Exclusion Criteria:

  • Hip OA
  • Severe osteoporosis
  • Fibromyalgia
  • Clinical history of tumors or cancer
  • Active inflammatory joint diseases (rheumatoid arthritis, gout)
  • Undergoing any joint replacement in the lower extremity
  • Neurological diseases (Parkinson's disease, stroke
  • Multiple sclerosis
  • muscular dystrophies
  • Diseases involving motor neurons
  • Alzheimer's disease
  • Infected wounds or osteomyelitis in the knee region
  • Deep vein thrombosis or thrombophlebitis
  • Sensory alteration in the lower limbs
  • Cognitive and cardiopulmonary impairment that may prevent or limit the execution of exercises
  • Use of a walking assistance device
  • History of recent knee trauma
  • Having undergone any form of treatment involving physical therapy
  • intra-articular
  • anti-inflammatory drugs
  • opioid medication or chondroprotective in the six months before the start of the interventions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
138 participants (estimated)

Study arms

  • Active comparator
    Therapeutic Exercise Group

    The therapeutic exercise program includes a warm-up, resistance, neuromuscular, mobility, and balance exercises.

    Other: Therapeutic Exercise

  • Experimental
    Therapeutic Exercises Group + Interferential Current

    The therapeutic exercise program includes a warm-up, resistance, neuromuscular, mobility, and balance exercises. However, the interferential current will be applied at the end of the therapeutic exercises. In this way, the IC will be used through a device (Endophasys® - NMS-0501, KLD Biosistemas® Equipamentos Eletrônicos Ltda). Four electrodes (8x5 cm), two upper and two lower (forming a square), will be positioned around the center of the knee. The parameters used were as follows: carrier current frequency of 4000 Hz; amplitude modulated frequency of 50 Hz; sweep frequency of 50 Hz; oscillation pattern of 1:1 second, and the amplitude of the current will be increased until the research participants report strong but comfortable and non-painful stimulation paresthesia. The IC will be applied for 30 minutes.

    Other: Therapeutic Exercise · Device: Interferential Current

  • Placebo comparator
    Therapeutic Exercises + placebo interferential current (ET + placebo IC) group

    The therapeutic exercise program includes a warm-up, resistance, neuromuscular, mobility, and balance exercises. However, the interferential current will be applied at the end of the therapeutic exercises. In this way, the IC will be used through a device (Endophasys® - NMS-0501, KLD Biosistemas® Equipamentos Eletrônicos Ltda). Four electrodes (8x5 cm), two upper and two lower (forming a square), will be positioned around the center of the knee.The device will only be turned on for the first minute.

    Other: Therapeutic Exercise · Device: placebo interferential current

Interventions

  • OtherTherapeutic Exercise

    The therapeutic exercise program includes a warm-up, resistance, neuromuscular, mobility, and balance exercises.

  • DeviceInterferential Current

    However, the interferential current will be applied at the end of the therapeutic exercises. In this way, the IC will be used through a device (Endophasys® - NMS-0501, KLD Biosistemas® Equipamentos Eletrônicos Ltda). Four electrodes (8x5 cm), two upper and two lower (forming a square), will be positioned around the center of the knee. The parameters used were as follows: carrier current frequency of 4000 Hz; amplitude modulated frequency of 50 Hz; sweep frequency of 50 Hz; oscillation pattern of 1:1 second, and the amplitude of the current will be increased until the research participants report strong but comfortable and non-painful stimulation paresthesia. The interferential current will be applied for 30 minutes.

  • Deviceplacebo interferential current

    However, the interferential current will be applied at the end of the therapeutic exercises. In this way, the IC will be used through a device (Endophasys® - NMS-0501, KLD Biosistemas® Equipamentos Eletrônicos Ltda). Four electrodes (8x5 cm), two upper and two lower (forming a square), will be positioned around the center of the knee. The parameters used were as follows: carrier current frequency of 4000 Hz; amplitude modulated frequency of 50 Hz; sweep frequency of 50 Hz; oscillation pattern of 1:1 second, and the amplitude of the current will be increased until the research participants report strong but comfortable and non-painful stimulation paresthesia. The device will only be turned on in the first minute

06

What researchers measure

Primary outcomes

  1. Reported pain

    Knee Injury and Osteoarthritis Outcome Score (KOOS). It aims to evaluate the domains of pain, symptoms, activities of daily living, function related to recreation and sports, and quality of life related to the knee. Totaling 42 items, each item must be answered using a Likert scale that ranges from 0 (best score) to 4 (worst score), and the score for each subscale ranges from 0 (worst score) to 100 (best score).

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

Secondary outcomes

  1. Numerical Pain Scale

    The Numerical rating pain scale, a simple, easily administered scale evaluates the perceived intensity of pain, using an 11-point scale from 0, representing 'no pain', to 10, which is the 'worst possible pain'.

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

  2. Functional disability

    Knee Injury and Osteoarthritis Outcome Score (KOOS). It aims to evaluate the domains of pain, symptoms, activities of daily living, function related to recreation and sports, and quality of life related to the knee. Totaling 42 items, each item must be answered using a Likert scale that ranges from 0 (best score) to 4 (worst score), and the score for each subscale ranges from 0 (worst score) to 100 (best score).

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

  3. Functional self-perception

    Pain self-efficacy questionnaire, structured into 10 items where each item is evaluated by selecting a number on a 7-point numerical scale (scores from 0 to 6), where 0 means "not at all confident" and 6 means "completely confident". The items cover different functions, from work, social activities, domestic tasks and coping with pain without medication. A total score is calculated from the sum of the scores for each of the 10 items, producing a total score that ranges from 0 to 60. Higher scores reflect stronger self-efficacy beliefs.

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

  4. Functional capacity

    Sit and stand test. The volunteer will sit down and stand up from a chair for 30 seconds. A researcher will time the total time it takes to complete this activity.

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

  5. Inability

    Patient-specific functional scale. The participant will indicate three activities that he/she has difficulty performing. For each of these activities, the participant will indicate a score from 0 to 10. Higher scores indicate how well the participant can perform the activity. Lower scores indicate an inability to perform the activity.

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

  6. Maximum voluntary isometric contraction

    manual dynamometer portable (Lafayette Manual Muscle System, Modelo 01165, Lafayette Instrument Company, Lafayette, IN). Four 5-second readings will be taken during maximal voluntary isometric contraction (MVIC) with a 30-second rest period between contractions. The first CIVM will familiarize the volunteer with carrying out the task. A new set of readings will be taken if a volunteer can perform three contractions with at least 10% variability. Strong and constant verbal stimuli will be used throughout the test. Always with the research participants' hands positioned crossed on the chest. Thus, bilateral assessments of the muscles, quadriceps, and gluteus medius will be carried out. The order of CIVM readings will be randomized to avoid collection bias. The research participant will remain in lateral decubitus with a pillow positioned between the legs, with the limb to be tested superiorly in a neutral position.

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

  7. Global Perception of Change scale

    The perception of the global effect of the treatment by the research participant will be evaluated by the Global Perception of Change scale. The Global Perception of Change scale is a direct scale on the patient's self-perception when the intervention is performed. This scale consists of 11 points, ranging from -5 (worsening compared to the start of treatment), 0 (neutral) and +5 (improvement compared to the start of treatment), using the Portuguese version.

    Time frame: before the first treatment session, after 8 weeks of treatment and 4 weeks after the end of the last session

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jun 2026, 17 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 17 months is close to that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 16, 2024
First posted
Dec 20, 2024
StartActual
Jan 20, 2025
Primary completionEst.
Jun 30, 2026
CompletionEst.
Jul 28, 2026
Last update
May 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06744036
Responsible party
Cid André Fidelis de Paula Gomes (Professor, University of Nove de Julho) — Principal investigator
First posted
Dec 20, 2024
Start date
Jan 20, 2025
Primary completion
Jun 30, 2026 (estimated)
Completion
Jul 28, 2026 (estimated)
Last update
May 22, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion